相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Performance evaluation of the Biocartis Idylla EGFR Mutation Test using pre-extracted DNA from a cohort of highly characterised mutation positive samples
Jack Grant et al.
JOURNAL OF CLINICAL PATHOLOGY (2022)
Rapid EGFR evaluation from used H&E, IHC and FISH diagnostic slides with the Idylla platform
Jose Nunnari et al.
JOURNAL OF CLINICAL PATHOLOGY (2022)
Reduced sensitivity for EGFR T790M mutations using the Idylla EGFR Mutation Test
Eric Lee et al.
JOURNAL OF CLINICAL PATHOLOGY (2021)
Rapid EGFR Mutation Detection Using the Idylla Platform Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing Results
Amir Momeni-Boroujeni et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2021)
EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies
Louise-Marie Chevalier et al.
ANNALES DE PATHOLOGIE (2020)
A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer
Susana Torres et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)
Evaluation of the Idylla system to detect the EGFRT790M mutation using extracted DNA
Claire Bocciarelli et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer
Claire Franczak et al.
PLOS ONE (2020)
Dual-molecular barcode sequencing detects rare variants in tumor and cell free DNA in plasma
Yosuke Hirotsu et al.
SCIENTIFIC REPORTS (2020)
Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer
Mercedes Delgado-Garcia et al.
BMC CANCER (2020)
Performance of the OncomineTM Lung cfDNA Assay for Liquid Biopsy by NGS of NSCLC Patients in Routine Laboratory Practice
Giuseppa De Luca et al.
APPLIED SCIENCES-BASEL (2020)
Rapid detection of EGFR mutations in decalcified lung cancer bone metastasis
Antoine Boureille et al.
JOURNAL OF BONE ONCOLOGY (2020)
Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers
Pauline Gilson et al.
SCIENTIFIC REPORTS (2020)
Rapid EGFR mutation testing in lung cancer tissue samples using a fully automated system and single-use cartridge
M. Rabie Al-Turkmani et al.
PRACTICAL LABORATORY MEDICINE (2020)
Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Forman-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer
Solene M. Evrard et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma
Richard Colling et al.
VIRCHOWS ARCHIV (2019)
Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades
Tao Lu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay
Qiao-mei Guo et al.
JOURNAL OF CANCER (2019)
Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients
J. Remon et al.
ANNALS OF ONCOLOGY (2018)
Are liquid biopsies a surrogate for tissue EGFR testing?
J. W. Goldman et al.
ANNALS OF ONCOLOGY (2018)
Overview of current systemic management of EGFR-mutant NSCLC
W. -H. Hsu et al.
ANNALS OF ONCOLOGY (2018)
Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm
Caterina De Luca et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
Neat I. Lindeman et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Christian Rolfo et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
A Comparative Study for Detection of EGFR Mutations in Plasma Cell-Free DNA in Korean Clinical Diagnostic Laboratories
Yoonjung Kim et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
100PComparison of OncoBEAM and NGS methods to detect plasma EGFR T790M mutations at progression of NSCLC
J Garcia et al.
ANNALS OF ONCOLOGY (2018)
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer
Umberto Malapelle et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Evaluation of a fast and fully automated platform to diagnose EGFR and KRAS mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day
Laetitia Lambros et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
T. S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer
Marius Ilie et al.
ONCOTARGET (2017)
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
Fabrice Barlesi et al.
LANCET (2016)
Circulating Cell-Free Tumour DNA in the Management of Cancer
Glenn Francis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients
Antonio Marchetti et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
Helena A. Yu et al.
CLINICAL CANCER RESEARCH (2013)
Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation
Geoffrey R. Oxnard et al.
CLINICAL CANCER RESEARCH (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Small cell lung cancer
Taimur Sher et al.
MAYO CLINIC PROCEEDINGS (2008)
Epidermal growth factor receptor mutations in lung cancer
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2007)
Epidermal growth factor receptor mutations in non-small-cell lung cancer:: Implications for treatment and tumor biology
PA Jänne et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
